ERVACCINE
Live / Registered — Registered (as of 28 Jan 2025)
What this means for you
Registered since 28 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97909881
- Registration number
- 7666330
- Mark type
- Stylized text
- Filed
- 27 Apr 2023
- Published for opposition
- 10 Dec 2024
- Registered
- 28 Jan 2025
- Attorney of record
- Pina Campagna
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer; therapeutic vaccines; Medical preparations, namely, T-cell therapy preparations for the treatment of cancer; stem cells for medical use; biological preparations for the prevention and treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the prevention and treatment of cancer; chemical preparations for medical purposes, namely, for the prevention or treatment of cancer; diagnostic preparations for medical purposes; medicinal preparations for the treatment of infectious diseases and for use in immunotherapy and oncology
- Class 042 — Scientific and technological services: Medical research laboratory services; biotechnological and pharmaceutical drug research and development services; pharmaceutical and biotechnological research and development; provision of medical and scientific research information in the field of pharmaceuticals; provision of medical and scientific research information in the field of therapeutic vaccines; provision of medical and scientific research information in the field of oncology, immunotherapy, stem cell therapy, and T-cell therapy; Providing medical and scientific research information in the field of clinical trials; screening and selection of molecules for scientific and pharmacological research purposes, not for medical purposes; research and development in the field of immunotherapy
- Class 044 — Medical, beauty and agricultural services: Medical and surgical services in the field of immunotherapy and oncology; medical diagnosis in the field of oncology, namely, medical diagnosis of cancer; medical testing for diagnostic or treatment purposes; provision of medical information in the field of immunotherapy and oncology; medical analysis for the diagnosis and treatment of persons; genetic testing services for medical purposes
Owner
- ERVIMMUNE, LYON CEDEX 08, FR
- ERVIMMUNE, LYON CEDEX 08, FR
- ERVIMMUNE, LYON CEDEX 08, FR
- Ervaccine Technologies, Lyon Cedex 08, FR
Prosecution history
- 22 Jul 2025 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
- 03 Jul 2025 — CORRECTION UNDER SECTION 7 - PROCESSED
- 18 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Jan 2025 — TEAS SECTION 7 REQUEST RECEIVED
- 28 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 10 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Dec 2024 — PUBLISHED FOR OPPOSITION
- 04 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Nov 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 09 Aug 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Aug 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Aug 2024 — ASSIGNED TO LIE
- 22 Feb 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED